Shirish M Gadgeel: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial

Rittmeyer, Achim, Barlesi, Fabrice, Waterkamp, Daniel, Park, Keunchil, Ciardiello, Fortunato, von Pawel, Joachim, Gadgeel, Shirish M, Hida, Toyoaki, Kowalski, Dariusz M, Dols, Manuel Cobo, Cortinovis,

Journal:

Year:

2017

Language:

english

File:

PDF, 1.32 MB

english, 2017

2

[Advances in Experimental Medicine and Biology] Lung Cancer and Personalized Medicine: Novel Therapies and Clinical Management Volume 890 || The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer

Ahmad, Aamir, Gadgeel, Shirish M.

Year:

2016

Language:

english

File:

PDF, 341 KB

english, 2016

3

Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer

Gandhi, Leena, Rodríguez-Abreu, Delvys, Gadgeel, Shirish, Esteban, Emilio, Felip, Enriqueta, De Angelis, Flávia, Domine, Manuel, Clingan, Philip, Hochmair, Maximilian J., Powell, Steven F., Cheng, Sus

Journal:

New England Journal of Medicine

Year:

2018

Language:

english

File:

PDF, 469 KB

english, 2018

4

Safety and activity of alectinib against systemic disease and brain metastases in patients with crizotinib-resistant ALK-rearranged non-small-cell lung cancer (AF-002JG): results from the dose-finding portion of a phase 1/2 study

Gadgeel, Shirish M, Gandhi, Leena, Riely, Gregory J, Chiappori, Alberto A, West, Howard L, Azada, Michele C, Morcos, Peter N, Lee, Ruey-Min, Garcia, Linta, Yu, Li, Boisserie, Frederic, Di Laurenzio, L

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 385 KB

english, 2014

5

Alectinib versus Crizotinib in Untreated ALK -Positive Non–Small-Cell Lung Cancer

Peters, Solange, Camidge, D. Ross, Shaw, Alice T., Gadgeel, Shirish, Ahn, Jin S., Kim, Dong-Wan, Ou, Sai-Hong I., Pérol, Maurice, Dziadziuszko, Rafal, Rosell, Rafael, Zeaiter, Ali, Mitry, Emmanuel, Go

Journal:

New England Journal of Medicine

Year:

2017

Language:

english

File:

PDF, 291 KB

english, 2017

6

Updated Efficacy and Safety Data and Impact of the EML4-ALK Fusion Variant on the Efficacy of Alectinib in Untreated ALK-Positive Advanced Non–Small Cell Lung Cancer in the Global Phase III ALEX Study

Camidge, D. Ross, Dziadziuszko, Rafal, Peters, Solange, Mok, Tony, Noe, Johannes, Nowicka, Malgorzata, Gadgeel, Shirish M., Cheema, Parneet, Pavlakis, Nick, de Marinis, Filippo, Cho, Byoung Chul, Zhan

Journal:

Journal of Thoracic Oncology

Year:

2019

Language:

english

File:

PDF, 506 KB

english, 2019

7

Pooled overall survival and safety data from the pivotal phase II studies (NP28673 and NP28761) of alectinib in ALK-positive non-small-cell lung cancer

Ou, Sai-Hong Ignatius, Gadgeel, Shirish M., Barlesi, Fabrice, Yang, James Chih-Hsin, De Petris, Luigi, Kim, Dong-Wan, Govindan, Ramaswamy, Dingemans, Anne-Marie, Crino, Lucio, Léna, Hervé, Popat, Sanj

Journal:

Year:

2020

Language:

english

File:

PDF, 1.07 MB

english, 2020

8

[Advances in Experimental Medicine and Biology] Lung Cancer and Personalized Medicine Volume 893 || Epidemiology of Lung Cancer

Ahmad, Aamir, Gadgeel, Shirish

Year:

2016

Language:

english

File:

PDF, 464 KB

english, 2016

9

[Advances in Experimental Medicine and Biology] Lung Cancer and Personalized Medicine: Novel Therapies and Clinical Management Volume 890 || Next-Generation Sequencing and Applications to the Diagnosis and Treatment of Lung Cancer

Ahmad, Aamir, Gadgeel, Shirish M.

Year:

2016

Language:

english

File:

PDF, 393 KB

english, 2016

10

The Natural Tumor Suppressor Protein Maspin and Potential Application in Non Small Cell Lung Cancer

Lonardo, Fulvio, Li, Xiaohua, Kaplun, Alexander, Soubani, Ayman, Sethi, Seema, Gadgeel, Shirish, Sheng, Shijie

Journal:

Current Pharmaceutical Design

Year:

2010

Language:

english

File:

PDF, 165 KB

english, 2010

11

Retreatment With Osimertinib Following Pneumonitis

Nagasaka, Misako, Gadgeel, Shirish M.

Journal:

Clinical Lung Cancer

Year:

2017

Language:

english

File:

PDF, 6.92 MB

english, 2017

12

The use of alectinib in the first-line treatment of anaplastic lymphoma kinase-positive non-small-cell lung cancer

Gadgeel, Shirish M

Journal:

Future Oncology

Year:

2018

Language:

english

File:

PDF, 1.27 MB

english, 2018

13

24-Month Overall Survival from KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin with or without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous Non–Small Cell Lung Cancer

Borghaei, Hossein, Langer, Corey J., Gadgeel, Shirish, Papadimitrakopoulou, Vassiliki A., Patnaik, Amita, Powell, Steven F., Gentzler, Ryan D., Martins, Renato G., Stevenson, James P., Jalal, Shadia I

Journal:

Journal of Thoracic Oncology

Year:

2018

Language:

english

File:

PDF, 576 KB

english, 2018

14

Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 study

Solomon, Benjamin J, Besse, Benjamin, Bauer, Todd M, Felip, Enriqueta, Soo, Ross A, Camidge, D Ross, Chiari, Rita, Bearz, Alessandra, Lin, Chia-Chi, Gadgeel, Shirish M, Riely, Gregory J, Tan, Eng Huat

Journal:

The Lancet Oncology

Year:

2018

Language:

english

File:

PDF, 1.30 MB

english, 2018

15

Detection of Known and Novel FGFR Fusions in Non–Small Cell Lung Cancer by Comprehensive Genomic Profiling

Qin, Angel, Johnson, Adrienne, Ross, Jeffrey S., Miller, Vincent A., Ali, Siraj M., Schrock, Alexa B., Gadgeel, Shirish M.

Journal:

Journal of Thoracic Oncology

Year:

2018

Language:

english

File:

PDF, 960 KB

english, 2018

16

Pembrolizumab in Combination With Erlotinib or Gefitinib as First-Line Therapy for Advanced NSCLC With Sensitizing EGFR Mutation

Yang, James Chih-Hsin, Gadgeel, Shirish M., Sequist, Lecia VanDam, Wu, Chien-Liang, Papadimitrakopoulou, Vassiliki A., Su, Wu-Chou, Fiore, Joseph, Saraf, Sanatan, Raftopoulos, Harry, Patnaik, Amita

Journal:

Journal of Thoracic Oncology

Year:

2019

Language:

english

File:

PDF, 243 KB

english, 2019

17

Combination pembrolizumab plus chemotherapy: a new standard of care for patients with advanced non-small-cell lung cancer

Weinberg, Frank, Gadgeel, Shirish

Journal:

Lung Cancer Targets and Therapy

Year:

2019

Language:

english

File:

PDF, 712 KB

english, 2019

18

Paclitaxel, cisplatin, and 5-fluorouracil for patients with advanced or recurrent squamous cell carcinoma of the head and neck

Maha Hussain, Shirish Gadgeel, Omer Kucuk, Wei Du, Walter Salwen, John Ensley

Journal:

Year:

1999

Language:

english

File:

PDF, 73 KB

english, 1999

19

Cost-effectiveness and lung cancer clinical trials

Wei Du, Jaxk H. Reeves, Shirish Gadgeel, Judith Abrams, William P. Peters

Journal:

Year:

2003

Language:

english

File:

PDF, 79 KB

english, 2003

20

Predictors of enrollment in lung cancer clinical trials

Wei Du, Shirish M. Gadgeel, Michael S. Simon

Journal:

Year:

2006

Language:

english

File:

PDF, 77 KB

english, 2006

21

Response to dual blockade of epidermal growth factor receptor (EGFR) and cycloxygenase-2 in nonsmall cell lung cancer may be dependent on the EGFR mutational status of the tumor

Shirish M. Gadgeel, Shadan Ali, Philip A. Philip, Fakhara Ahmed, Antoinette Wozniak, Fazlul H. Sarkar

Journal:

Year:

2007

Language:

english

File:

PDF, 332 KB

english, 2007

22

Genistein enhances the effect of epidermal growth factor receptor tyrosine kinase inhibitors and inhibits nuclear factor kappa B in nonsmall cell lung cancer cell lines

Shirish M. Gadgeel, Shadan Ali, Philip A. Philip, Antoinette Wozniak, Fazlul H. Sarkar

Journal:

Year:

2009

Language:

english

File:

PDF, 782 KB

english, 2009

23

Patterns of care in a population-based sample of soft tissue sarcoma patients in the United States

Shirish M. Gadgeel, Linda C. Harlan, Christopher A. Zeruto, Michael Osswald, Ann G. Schwartz

Journal:

Year:

2009

Language:

english

File:

PDF, 137 KB

english, 2009

24

Retrospective review of cancer patients ≥80 years old treated with chemotherapy at a comprehensive cancer center

Minsig Choi, Peter Q. Jiang, Lance K. Heilbrun, Daryn W. Smith, Shirish M. Gadgeel

Journal:

Critical Reviews in Oncology/Hematology

Year:

2008

Language:

english

File:

PDF, 174 KB

english, 2008

25

An educational video to increase clinical trials enrollment among breast cancer patients

Wei Du, Darlene Mood, Shirish Gadgeel, Michael S. Simon

Journal:

Breast Cancer Research and Treatment

Year:

2009

Language:

english

File:

PDF, 260 KB

english, 2009

26

A phase I study of flavopiridol and docetaxel

Basil F. El-Rayes, Shirish Gadgeel, Ralph Parchment, Patricia Lorusso, Philip A. Philip

Journal:

Investigational New Drugs

Year:

2006

Language:

english

File:

PDF, 177 KB

english, 2006

27

A phase 1 trial of XK469: Toxicity profile of a selective topoisomerase IIβ inhibitor

Amin M. Alousi, Ramesh Boinpally, Richard Wiegand, Ralph Parchment, Shirish Gadgeel, Lance K. Heilbrun, Antionette J. Wozniak, Pamela DeLuca, Patricia M. LoRusso

Journal:

Investigational New Drugs

Year:

2007

Language:

english

File:

PDF, 380 KB

english, 2007

28

Phase I clinical evaluation of ZD6126, a novel vascular-targeting agent, in patients with solid tumors

Patricia M. LoRusso, Shirish M. Gadgeel, Antoinette Wozniak, Alan J. Barge, Helen K. Jones, Zachary S. DelProposto, Pamela A. DeLuca, Jeffrey L. Evelhoch, Scott A. Boerner, Catherine Wheeler

Journal:

Investigational New Drugs

Year:

2008

Language:

english

File:

PDF, 215 KB

english, 2008

29

Phase II trial of fenretinide (NSC 374551) in patients with recurrent small cell lung cancer

Bryan J. Schneider, Francis P. Worden, Shirish M. Gadgeel, Ralph E. Parchment, Collette M. Hodges, James Zwiebel, Rodney L. Dunn, Antoinette J. Wozniak, Michael J. Kraut, Gregory P. Kalemkerian

Journal:

Investigational New Drugs

Year:

2009

Language:

english

File:

PDF, 148 KB

english, 2009

30

Cediranib in combination with various anticancer regimens: results of a phase I multi-cohort study

Patricia LoRusso, Anthony F. Shields, Shirish Gadgeel, Ulka Vaishampayan, Tina Guthrie, Thomas Puchalski, John Xu, Qi Liu

Journal:

Investigational New Drugs

Year:

2011

Language:

english

File:

PDF, 412 KB

english, 2011

31

The Optimal Chemotherapy for Stage III Non–Small Cell Lung Cancer Patients

Shirish M. Gadgeel

Journal:

Current Oncology Reports

Year:

2011

Language:

english

File:

PDF, 146 KB

english, 2011

32

Racial differences in lung cancer

Shirish M. Gadgeel, Gregory P. Kalemkerian

Journal:

Cancer and Metastasis Reviews

Year:

2003

Language:

english

File:

PDF, 235 KB

english, 2003

33

Analysis of Lung Cancer Patients Enrolled in CTEP (Cancer Therapy Evaluation Program)-Sponsored Phase I Trials

Shirish M. Gadgeel, Percy Ivy, Wei Chen, Joan Mauer, Daryn Smith, Patricia LoRusso

Journal:

Clinical Lung Cancer

Year:

2011

Language:

english

File:

PDF, 382 KB

english, 2011

34

Safety Profile and Tolerability of Antiangiogenic Agents in Non–Small-Cell Lung Cancer

Shirish M. Gadgeel

Journal:

Clinical Lung Cancer

Year:

2012

Language:

english

File:

PDF, 424 KB

english, 2012

35

Mature Results of a Phase II Trial of Gemcitabine/Paclitaxel Given Every 2 Weeks in Patients with Advanced Non–Small-Cell Lung Cancer

Antoinette J. Wozniak, Kimberly Belzer, Lance K. Heilbrun, Omer Kucuk, Shirish Gadgeel, Gregory P. Kalemkerian, Raghu Venkatramanamoorthy, Michael J. Kraut

Journal:

Clinical Lung Cancer

Year:

2007

Language:

english

File:

PDF, 125 KB

english, 2007

36

Targeted Therapy in Lung Cancer: The Good, the Bad, and the Ugly

Shirish M. Gadgeel

Journal:

Clinical Lung Cancer

Year:

2009

Language:

english

File:

PDF, 66 KB

english, 2009

37

Parameters for individualizing systemic therapy in non-small cell lung cancer

Shirish M. Gadgeel, Michele L. Cote, Ann G. Schwartz, Larry H. Matherly, Antoinette Wozniak, Gerold Bepler

Journal:

Drug Resistance Updates

Year:

2010

Language:

english

File:

PDF, 385 KB

english, 2010

38

Soy isoflavones radiosensitize lung cancer while mitigating normal tissue injury

Gilda G. Hillman, Vinita Singh-Gupta, Lindsay Runyan, Christopher K. Yunker, Joseph T. Rakowski, Fazlul H. Sarkar, Steven Miller, Shirish M. Gadgeel, Seema Sethi, Michael C. Joiner, Andre A. Konski

Journal:

Radiotherapy and Oncology

Year:

2011

Language:

english

File:

PDF, 1.88 MB

english, 2011

39

O-110 Preliminary results of a phase II study of celecoxib and weekly docetaxel in elderly (> 70 yrs) or PS2 patients with advanced non-small cell lung cancer (NSCLC)

Gadgeel, Shirish M., Shehadeh, Nasfet, Kraut, Michael J., Wozniak, Antoinette, Belzer, Kimberly, Ward, Deborah, Hodges, Collette, Parchment, Ralph, Chaplen, Ruth, Kalemkerian, Gregory P.

Journal:

Year:

2003

Language:

english

File:

PDF, 189 KB

english, 2003

40

P-565 Phase II study of Fenretinide in patients with small cell lung cancer (SCLC) with progression after first- or second-line chemotherapy

Schneider, Bryan, Worden, Francis P., Gadgeel, Shirish M., Hodges, Collette M., Parchment, Ralph E., Zwiebel, James A., Kraut, Michael J., Kalemkerian, Gregory P.

Journal:

Year:

2003

Language:

english

File:

PDF, 178 KB

english, 2003

41

Malignant mesothelioma

Shirish M. Gadgeel, Harvey I. Pass

Journal:

Community Oncology

Year:

2006

Language:

english

File:

PDF, 227 KB

english, 2006

42

A phase 2 study of TZT-1027, administered weekly to patients with advanced non-small cell lung cancer following treatment with platinum-based chemotherapy

Riely, Gregory J., Gadgeel, Shirish, Rothman, Ivan, Saidman, Bruce, Sabbath, Kert, Feit, Kevie, Kris, Mark G., Rizvi, Naiyer A.

Journal:

Year:

2007

Language:

english

File:

PDF, 158 KB

english, 2007

43

Biochemotherapy of melanoma

Lawrence E Flaherty, Shirish M Gadgeel

Journal:

Seminars in Oncology

Year:

2002

Language:

english

File:

PDF, 92 KB

english, 2002

44

Novel Combinations Using Pemetrexed in Malignant Mesothelioma

Shirish M. Gadgeel, Harvey I. Pass

Journal:

Clinical Lung Cancer

Year:

2004

Language:

english

File:

PDF, 126 KB

english, 2004

45

Phase II Trial of Imatinib Maintenance Therapy After Irinotecan and Cisplatin in Patients With c-Kit–Positive, Extensive-Stage Small-Cell Lung Cancer

Bryan J. Schneider, Gregory P. Kalemkerian, Nithya Ramnath, Michael J. Kraut, Antoinette J. Wozniak, Francis P. Worden, John C. Ruckdeschel, Xiaohui Zhang, Wei Chen, Shirish M. Gadgeel

Journal:

Clinical Lung Cancer

Year:

2010

Language:

english

File:

PDF, 116 KB

english, 2010

46

Treatment of Lung Cancer

Gadgeel, Shirish M., Ramalingam, Suresh S., Kalemkerian, Gregory P.

Journal:

Radiologic Clinics of North America

Year:

2012

Language:

english

File:

PDF, 248 KB

english, 2012

47

Preclinical Rationale for PI3K/Akt/mTOR Pathway Inhibitors as Therapy for Epidermal Growth Factor Receptor Inhibitor-Resistant Non–Small-Cell Lung Cancer

Gadgeel, Shirish M., Wozniak, Antoinette

Journal:

Clinical Lung Cancer

Year:

2013

Language:

english

File:

PDF, 1.54 MB

english, 2013

48

New Targets in Non-Small Cell Lung Cancer

Shirish M. Gadgeel

Journal:

Current Oncology Reports

Year:

2013

Language:

english

File:

PDF, 228 KB

english, 2013

49

Differential effect of soy isoflavones in enhancing high intensity radiotherapy and protecting lung tissue in a pre-clinical model of lung carcinoma

Hillman, Gilda G., Singh-Gupta, Vinita, Hoogstra, David J., Abernathy, Lisa, Rakowski, Joseph, Yunker, Christopher K., Rothstein, Shoshana E., Sarkar, Fazlul H., Gadgeel, Shirish, Konski, Andre A., Lo

Journal:

Radiotherapy and Oncology

Year:

2013

Language:

english

File:

PDF, 2.43 MB

english, 2013

50

Phase I study evaluating the combination of lapatinib (a Her2/Neu and EGFR inhibitor) and everolimus (an mTOR inhibitor) in patients with advanced cancers: South West Oncology Group (SWOG) Study S0528

Gadgeel, Shirish M., Lew, Danika L., Synold, Timothy W., LoRusso, Patricia, Chung, Vincent, Christensen, Scott D., Smith, David C., Kingsbury, Laura, Hoering, Antje, Kurzrock, Razelle

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2013

Language:

english

File:

PDF, 400 KB

english, 2013